About
Golden Helix delivers enterprise-grade genomic infrastructure for clinical diagnostic laboratories, hospitals, and genome centers. Its flagship VarSeq Suite integrates variant analysis, interpretation, and reporting in one unified platform, supporting germline gene panels, exome and whole genome sequencing, somatic cancer variants, pharmacogenomics (PGx), and prenatal applications. The platform is built around clinical reliability and regulatory compliance, operating under an ISO 13485-certified quality management system. Institutions can deploy Golden Helix on-premises, in a private cloud, or in fully air-gapped environments — patient data never touches Golden Helix servers, ensuring complete data sovereignty. Key components include VarSeq Suite for end-to-end variant analysis and clinical reporting, VSWarehouse for enterprise genomic data management and scalable research programs, and Sentieon integration for high-performance secondary analysis including alignment and variant calling at production scale. Clinical interpretation follows AMP, ACMG, CPIC, and FDA guidelines, enabling standardized and defensible variant classification across cancer and germline programs. Automated workflows reduce manual effort and improve repeatability, while rich visualization tools support complex bioinformatic decisions. Golden Helix is ideal for clinical genomics teams seeking a comprehensive, auditable, and customizable solution that scales from small gene panels to population-level whole genome programs. With over 25 years in business and hundreds of product installs, it is a proven partner for precision medicine and diagnostic genomics.
Key Features
- Unified Clinical Variant Analysis: VarSeq Suite integrates variant analysis, interpretation, and clinical reporting in a single platform covering germline, oncology, prenatal, and pharmacogenomics workflows.
- On-Premises & Private Cloud Deployment: Full data sovereignty with on-prem, private cloud, or air-gapped deployment options — patient data never leaves your infrastructure.
- Guideline-Aligned Interpretation: Variant classification follows AMP, ACMG, CPIC, and FDA guidelines, ensuring clinically defensible and standardized results across all application areas.
- Enterprise Data Management with VSWarehouse: VSWarehouse provides scalable genomic data management for clinical and research programs, enabling enterprise-level storage, querying, and reporting.
- High-Performance Secondary Analysis via Sentieon: Integrated Sentieon support delivers production-scale alignment and variant calling for high-throughput sequencing environments.
Use Cases
- Diagnostic laboratories interpreting germline variants from gene panels, exomes, or whole genomes for rare disease diagnosis.
- Oncology programs performing somatic variant analysis and clinical reporting for cancer patients following AMP/ACMG guidelines.
- Hospital genomics departments managing pharmacogenomics (PGx) testing to guide drug prescribing decisions.
- Genome centers running high-throughput NGS pipelines requiring production-scale secondary analysis and enterprise data management.
- Institutions with strict data governance requirements deploying air-gapped or private cloud genomic analysis infrastructure.
Pros
- Complete Data Sovereignty: Flexible deployment options (on-prem, private cloud, air-gapped) ensure sensitive patient genomic data never leaves the institution's control.
- Comprehensive Clinical Coverage: Supports germline, somatic cancer, pharmacogenomics, and prenatal workflows in one integrated platform, reducing the need for multiple tools.
- Regulatory Compliance & Quality Management: ISO 13485-certified quality management system and adherence to major clinical guidelines (AMP, ACMG, CPIC, FDA) supports diagnostic-grade deployments.
- Strong User Support & Training: Consistently praised by users for excellent technical support, training resources, and responsiveness to feature requests.
Cons
- Enterprise Pricing: As a premium clinical platform, Golden Helix is priced for institutional buyers and may be cost-prohibitive for smaller labs or individual researchers.
- Complexity for New Users: The breadth of features and configuration options can present a steep learning curve for teams without dedicated bioinformatics staff.
- No Public SaaS Option: The platform is designed for private deployment, which requires IT infrastructure investment and is not available as a shared cloud service.
Frequently Asked Questions
What types of genomic analyses does Golden Helix support?
Golden Helix supports germline gene panel, exome, and whole genome analysis; somatic cancer variant interpretation; pharmacogenomics (PGx); and prenatal genomic workflows.
Where can Golden Helix software be deployed?
Golden Helix can be deployed on-premises, in a private cloud environment, or in fully air-gapped setups. Patient data never passes through Golden Helix servers.
What clinical guidelines does Golden Helix follow for variant interpretation?
The platform aligns with AMP and ACMG guidelines for germline and somatic variants, and CPIC and FDA recommendations for pharmacogenomics.
What is VarSeq and how does it differ from VSWarehouse?
VarSeq is the clinical variant analysis, interpretation, and reporting platform. VSWarehouse is an enterprise data management solution for storing, querying, and scaling genomic data across clinical and research programs.
Is Golden Helix suitable for smaller clinical laboratories?
Golden Helix is primarily designed for diagnostic laboratories, hospitals, and genome centers with existing bioinformatics infrastructure. Smaller labs should contact Golden Helix to evaluate fit and pricing for their scale.
